Want to do a quick performance check on your Linux system? You might want to take a look at the dstat command. Linux provides a number of commands that provide information about disk and system ...

Chimerix Inc (NASDAQ: CMRX) reports topline results from the first cohort (n=12) of its Phase 2/3 study evaluating DSTAT in hospitalized patients with Acute Lung Injury (ALI) and COVID-19 infection.

The Dstat.cc DDoS review platform has been seized by law enforcement, and two suspects have been arrested after the service helped fuel distributed denial-of-service attacks for years. The seizure and ...

It's a rare occasion that my Linux desktop slows down. That's not to say it never happens, as that would be a lie. Most often, when a system slowdown occurs, I can usually trace it back to a specific ...

The Dstat.cc DDoS review platform has been seized by law enforcement, and two suspects have been arrested after the service helped fuel distributed denial-of-service attacks for years.

All six DSTAT patients met the improvement criteria compared to two of the six placebo patients. DURHAM, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company ...

DURHAM, N.C., April 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, ...

A Durham-based biopharmaceutical company says it has gotten the okay from the Food and Drug Administration to test its experimental cancer drug on COVID-19 patients in the U.S. The company, Chimerix, ...

A company developing a drug derived from the blood thinner heparin for a form of leukemia is planning to test it in patients with Covid-19 due to its anti-inflammatory and anti-clotting properties.

Wired reported this week that a 19-year-old working for Elon Musk’s so-called Department of Government Efficiency (DOGE) was given access to sensitive US government systems even though his past ...

DURHAM, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, ...